Morgan Stanley
- SEC CIK
- 0000895421
- Latest filing
- Aug 13, 2026
ENSC holding history
Ensysce Biosciences, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ENSC overviewAll 13F holders of ENSCFull Q2 2026 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −378−100.0% | Sold out | Holders |
| Q2 2025 | 378 | $843 | <0.1% | +378 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −52−100.0% | Sold out | Holders |
| Q4 2024 | 52 | $423 | <0.1% | +52 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −276−100.0% | Sold out | Holders |
| Q4 2022 | 276 | $207 | <0.1% | +276+183,900.0% | AddedConverted for a 1-for-20 split | Holders |
| Q3 2022 | 3 | $0 | 0.0% | −267−98.9% | Reduced | Holders |
| Q2 2022 | 270 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q1 2022 | 270 | $0 | 0.0% | −39−12.6% | Reduced | Holders |
| Q4 2021 | 309 | $1.00K | <0.1% | −2,960−90.5% | Reduced | Holders |
| Q3 2021 | 3,269 | $10.0K | <0.1% | +3,269 | New | Holders |